Medical Condition News

RSS

MDI Biological Laboratory scientist identifies potential drug therapy to reverse peripheral nerve damage

The Mount Desert Island Biological Laboratory has announced that assistant professor Sandra Rieger, Ph.D., has identified two drugs that could potentially be used to reverse peripheral nerve damage, or peripheral neuropathy, resulting from chemotherapy treatment for ovarian, breast, lung, pancreas and other cancers. The drugs also have potential applications for the treatment of peripheral nerve damage caused by diabetes, traumatic injuries and other conditions.

23 Feb 2016

Black, white Americans cope with pain differently

Researchers led by Adam T. Hirsh of the School of Science at Indiana University-Purdue University Indianapolis report that black and white Americans cope with pain differently and that blacks employ pain coping strategies more frequently than whites. The IUPUI review and analysis of 19 studies is the first to examine the entire published literature and quantify the relationship between race and the use of pain-coping strategies.

23 Feb 2016

Natural sugar could become contrast agent for detecting malignant tumours

Ordinary sugar could become a contrast agent of the future for use in magnetic resonance tomography examinations of tumours. Malignant tumours show higher sugar consumption than surrounding tissue.

23 Feb 2016

Researchers devise new approach to improve current T-cell therapy methods

T-cell therapy, a form of immunotherapy that uses a patient's own immune cells to attack their cancer, has been making waves recently. The "living" therapy involves engineering the patient's T cells in the laboratory to carry new proteins that guide the immune cells directly to tumor cells, allowing the engineered T cells to attack and kill the cancer.

23 Feb 2016

National Stroke Association reports positive outcomes from Stroke Recovery Navigator program

National Stroke Association released today the promising results from the pilot of its Stroke Recovery Navigator program (SRN) at the International Stroke Conference in Los Angeles.

23 Feb 2016

UAB researchers use Malvern’s NanoSight NS300 system to figure out role of exosomes in disease transmission

Data measured using the NanoSight NS300 from Malvern Instruments is providing new insights into the role of exosomes in diseases such as cancer, arthritis, Alzheimer’s disease and cystic fibrosis, in pioneering research at the University of Alabama - Birmingham (UAB).

23 Feb 2016

Researchers Pinpoint Potential Enzyme For T-Cell Leukemia Treatment

For the first time, researchers at Boston University have shown that T-cell leukemia cells use a particular cycle, called the TCA or Kreb cycle, to support their growth and survival.

23 Feb 2016

Cardiac clot-busting drug decreases mortality in hemorrhagic stroke patients

Reporting on the results of a phase III international clinical trial, Johns Hopkins Medicine physicians say use of a cardiac clot-busting drug to treat strokes that cause brain bleeding safely decreased the death rate in patients by 10 percent, compared to a control group receiving saline.

23 Feb 2016

New clinical trial focuses on respiratory drug ambroxol for treatment of Parkinson's disease

A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson's disease.

23 Feb 2016

Hiroshima University researchers identify new class of cancer-causing genetic variations

Researchers at Hiroshima University have opened the door to finding a new class of cancer-causing genetic variations.

23 Feb 2016

Pitt experts lead gene therapy clinical trial in Parkinson's disease patients

Experts at the University of Pittsburgh School of Medicine are leading the second arm of a clinical trial using gene therapy to relieve the symptoms of tremor and mobility impairment in patients with Parkinson's disease.

23 Feb 2016

Lucideon adds accelerated aging of UHMWPE orthopedic implants to wear and fatigue testing services

Lucideon, the international materials technology company, is pleased to announce that it has added accelerated aging of UHMWPE polymer orthopedic implants to its range of wear and fatigue testing services.

23 Feb 2016

UA College of Pharmacy assistant professor developing dry powder inhalers to treat pulmonary diseases

Heidi M. Mansour, PhD, assistant professor in the University of Arizona College of Pharmacy, is working to develop advanced dry powder inhalers to treat and prevent pulmonary diseases.

23 Feb 2016

Losing just 5% of weight has significant health benefits for patients with obesity

For patients with obesity trying to lose weight, the greatest health benefits come from losing just 5 percent of their body weight, according to a new study at Washington University School of Medicine in St. Louis.

23 Feb 2016

UCSF study finds specific molecular-genetic mechanism that links sleep and seasonal depression

A newly discovered human gene mutation appears to contribute both to unusual sleep patterns and to heightened rates of seasonal depression, according to new research from UC San Francisco.

23 Feb 2016

Partner's lifestyle has greater influence on obesity risk

The lifestyle a person shares with their partner has a greater influence on their chances of becoming obese than their upbringing, research suggests.

23 Feb 2016

Light-to-moderate drinking can be good for your heart

Drinking a little alcohol every day may be part of a healthy lifestyle, according to Imre Janszky, a professor of social medicine at the Norwegian University of Science and Technology. He says alcohol does more good than harm for your heart when consumed in moderation.

23 Feb 2016

Consuming dried plums can protect from radiation-induced bone loss

Dr. Nancy Turner, a Texas A&M AgriLife Research scientist in College Station, was one of a team of researchers who recently studied different interventions to protect from radiation-induced bone loss.

23 Feb 2016

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

The U.S. Food and Drug Administration approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of patients eligible to receive ALK tyrosine kinase inhibitor (TKI) treatment.

23 Feb 2016

Patient enrollment completed in vepoloxamer Phase 3 study for treatment of sickle cell disease

Mast Therapeutics, Inc., a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure today announced that it has completed patient enrollment in its Phase 3 clinical study of vepoloxamer for the treatment of patients with sickle cell disease experiencing vaso-occlusive crisis, known as the EPIC study.

22 Feb 2016

Medical Condition News

MDI Biological Laboratory scientist identifies potential drug therapy to reverse peripheral nerve damage

Black, white Americans cope with pain differently

Natural sugar could become contrast agent for detecting malignant tumours

Researchers devise new approach to improve current T-cell therapy methods

National Stroke Association reports positive outcomes from Stroke Recovery Navigator program

UAB researchers use Malvern’s NanoSight NS300 system to figure out role of exosomes in disease transmission

Researchers Pinpoint Potential Enzyme For T-Cell Leukemia Treatment

Cardiac clot-busting drug decreases mortality in hemorrhagic stroke patients

New clinical trial focuses on respiratory drug ambroxol for treatment of Parkinson's disease

Hiroshima University researchers identify new class of cancer-causing genetic variations

Pitt experts lead gene therapy clinical trial in Parkinson's disease patients

Lucideon adds accelerated aging of UHMWPE orthopedic implants to wear and fatigue testing services

UA College of Pharmacy assistant professor developing dry powder inhalers to treat pulmonary diseases

Losing just 5% of weight has significant health benefits for patients with obesity

UCSF study finds specific molecular-genetic mechanism that links sleep and seasonal depression

Partner's lifestyle has greater influence on obesity risk

Light-to-moderate drinking can be good for your heart

Consuming dried plums can protect from radiation-induced bone loss

FDA-approved VENTANA anti-ALK CDx more accurate than commonly used IHC assay for patient selection

Patient enrollment completed in vepoloxamer Phase 3 study for treatment of sickle cell disease

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News